Fuller & Thaler Asset Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-193,940
| Closed | -$3.6M | – | 558 |
|
|
2023
Q3 | $3.6M | Sell |
193,940
-7,520
| -4% | -$139K | 0.02% | 306 |
|
|
2023
Q2 | $2.23M | Buy |
+201,460
| New | +$2.23M | 0.01% | 349 |
|
|
2022
Q3 | – | Sell |
-165,310
| Closed | -$2.28M | – | 509 |
|
|
2022
Q2 | $2.28M | Buy |
165,310
+1,100
| +0.7% | +$15.2K | 0.02% | 336 |
|
|
2022
Q1 | $2.67M | Buy |
164,210
+825
| +0.5% | +$13.4K | 0.02% | 344 |
|
|
2021
Q4 | $2.66M | Buy |
+163,385
| New | +$2.66M | 0.02% | 337 |
|
|
2015
Q1 | – | Sell |
-200
| Closed | -$31K | – | 723 |
|
|
2014
Q4 | $31K | Sell |
200
-800
| -80% | -$124K | ﹤0.01% | 601 |
|
|
2014
Q3 | $237K | Buy |
+1,000
| New | +$237K | 0.01% | 404 |
|